Patent ID: 8168657

Claim:
A method of treating a tumor or cancer in a patient in need thereof comprising administering to said patient a pharmaceutical composition in oral, topical or systemic dosage form comprising an effective amount of a compound having the structure: wherein R 1 is a methyl group and R 2 is an undecyl group or a pharmaceutically acceptable salt thereof, in combination with a pharmaceutically acceptable carrier, additive or excipient, wherein said tumor is selected from the group consisting of neurofibromatosis, tuberous sclerosis and hemangiomas and said cancer is selected from the group consisting of cervical, uterine, anal, ocular, stomach, colon, bladder, rectal, kidney, liver, pancreatic, lung, breast, ovarian, prostate, testicular, renal, brain/cns, head and neck, throat, esophageal, mouth, pharynx, larynx, Ewing's Sarcoma, Kaposi's Sarcoma, melanoma, basal cell carcinoma, small cell lung, squamous cell carcinoma, choriocarcinoma, rhabdomyosarcoma, angiosarcoma, Wilms Tumor, neuroblastoma and lymphoma.